Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target ...

Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Apple ( AAPL) supplier Skyworks Solutions ( SWKS) saw its stock drop more than 23% Thursday as the semiconductor firm said that it's losing business with the iPhone maker to one of its competitors, ...

Now that Groundhog Day has come and gone, the second half of winter is among us, which means all the weirdos start coming out ...

On Nov. 30, 2024, Shiffrin hit two gates and crashed into a fence in her second run of a giant slalom race in the Stifel Killington Cup in Killington, Vermont. The accident resulted in an ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...

(Bloomberg) -- Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The ...